Document Detail


Ocular effects in long-term amiodarone therapy.
MedLine Citation:
PMID:  6613837     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The ocular complications of long-term amiodarone therapy have been recognized for many years, but systematic data on the prognostic significance and the precise incidence of such effects have not been evaluated until recently. One hundred seventy-five patients receiving long-term amiodarone treatment have thus been followed for periods ranging from 3 months to nearly 10 years. Of 103 of these patients studied in greater depth, 98% have shown the characteristic patterns of corneal microdeposits, which progressed over several months and ultimately formed a stable appearance that changed only with an alteration of dose. The abnormalities, the nature of which is not clearly understood, disappeared within 7 months in the 16 patients whose drug was withdrawn for unrelated reasons, and no permanent ocular damage has been detected. Visual symptoms associated with the corneal deposits developed in 6% of patients: 3% had photophobia, 2% halos, and 1% blurring of vision but without impairment of visual acuity. It is concluded that ocular complications of amiodarone therapy are insignificant; they do not pose a threat to vision, and routine ophthalmologic surveillance does not appear mandatory in the majority of patients during long-term drug therapy.
Authors:
D V Ingram
Related Documents :
2357777 - Potassium loading as adjunct treatment of repetitive ventricular arrhythmias.
9116967 - Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard ...
16638947 - Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-ana...
10598887 - Thrombolytic therapy can reduce the arrhythmogenic substrate after acute myocardial inf...
10857517 - Therapeutic selective nerve root block in the nonsurgical treatment of atraumatic cervi...
21817157 - Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensor...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American heart journal     Volume:  106     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1983 Oct 
Date Detail:
Created Date:  1983-10-28     Completed Date:  1983-10-28     Revised Date:  2006-02-27    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  902-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amiodarone / administration & dosage,  adverse effects*,  therapeutic use
Benzofurans / adverse effects*
Corneal Diseases / chemically induced,  pathology
Eye Diseases / chemically induced*
Humans
Vision Disorders / chemically induced
Chemical
Reg. No./Substance:
0/Benzofurans; 1951-25-3/Amiodarone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Control of sudden recurrent arrhythmic deaths: role of amiodarone.
Next Document:  Side effects and possible contraindications of amiodarone use.